About Hyasynth Bio
Hyasynth Bio is a company based in Montreal (Canada) founded in 2014 by Zach Wiltshire, Alex Campbell, and Shoham Mookerjee.. Hyasynth Bio has raised $11.04 million across 5 funding rounds from investors including Organigram, Anges Québec and SOSV. Hyasynth Bio operates in a competitive market with competitors including IGC Pharma, Hempsana, Pike Therapeutics, Soul Biotech and Nura Lyfe Sciences, among others.
- Headquarter Montreal, Canada
- Founders Zach Wiltshire, Alex Campbell, Shoham Mookerjee
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.04 M (USD)
in 5 rounds
-
Latest Funding Round
$2.5 M (USD), Series A
Dec 22, 2021
-
Investors
Organigram
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Hyasynth Bio
Hyasynth Bio has successfully raised a total of $11.04M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.5 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $2.5M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series A - Hyasynth Bio | Valuation |
investors |
|
| Oct, 2020 | Amount | Series A - Hyasynth Bio | Valuation | Organigram |
|
| Sep, 2018 | Amount | Series A - Hyasynth Bio | Valuation | Organigram |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hyasynth Bio
Hyasynth Bio has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Organigram, Anges Québec and SOSV. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investment network supporting innovative entrepreneurs in Canada.
|
Founded Year | Domain | Location | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location | |
|
Provider of cannabis products, brands, and international business development investments
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hyasynth Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hyasynth Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hyasynth Bio Comparisons
Competitors of Hyasynth Bio
Hyasynth Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IGC Pharma, Hempsana, Pike Therapeutics, Soul Biotech and Nura Lyfe Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products targeting neurological disorders like Alzheimer's are developed.
|
|
| domain | founded_year | HQ Location |
CBD oil processing solutions from hemp plants are provided.
|
|
| domain | founded_year | HQ Location |
Developer of psychedelic and cannabinoid therapeutics
|
|
| domain | founded_year | HQ Location |
Psychedelics, mushrooms, and cannabinoids are developed for mental health treatments.
|
|
| domain | founded_year | HQ Location |
Delivers comprehensive psychedelic and cannabinoid therapeutics for neurological disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hyasynth Bio
Frequently Asked Questions about Hyasynth Bio
When was Hyasynth Bio founded?
Hyasynth Bio was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Hyasynth Bio located?
Hyasynth Bio is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Is Hyasynth Bio a funded company?
Hyasynth Bio is a funded company, having raised a total of $11.04M across 5 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jun 01, 2015.
What does Hyasynth Bio do?
Developer of cannabinoid products intended to treat neurological disorders. The companys products are made using technologies traditional and modern biology combined with computational insights to develop organisms and to treat multiple sclerosis, epilepsy, Alzheimers diseases, and others.
Who are the top competitors of Hyasynth Bio?
Hyasynth Bio's top competitors include IGC Pharma, Pike Therapeutics and Soul Biotech.
Who are Hyasynth Bio's investors?
Hyasynth Bio has 3 investors. Key investors include Organigram, Anges Québec, and SOSV.